Antifungal susceptibility of Acremonium species using E-test® and Sensititre®;Sensibilidad a antifúngicos de especies de Acremonium mediante los métodos E-test® y Sensititre®

Revista Espanola de Quimioterapia

Volumn 17, Issue 1, 2004, Pages 44-47

  Saldarreaga, Abel ^a,b   Garcia Martos P ^a   Ruiz Aragon J ^a   Garcia Agudo L ^a   Montes De Oca, M ^a   Puerto, J L ^a   Marin P ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

^b NONE   (Spain)

Author keywords

Acremonium; Antifungal; Fungal infection; Susceptibility test

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE;

ACREMONIUM; ANALYTIC METHOD; ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG CHOICE; DRUG INDICATION; FUNGUS ISOLATION; IN VITRO STUDY; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; NONHUMAN; SPECIES COMPARISON;

ACREMONIUM; AMPHOTERICIN B; ANTIFUNGAL AGENTS; FLUCONAZOLE; HUMANS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS;

EID: 2542493085     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. De Battle, J., Motje, M., Guardia, R., Ortiz, R. Disseminated infection caused by Scedosporium prolificans in a patient with acute multilineal leukemia. J Clin Microbiol 2000; 38: 1694-1695.
2. Guarro, J., Gené, J. Opportunistic fusarial infections in humans. Eur J Clin Microbiol Infect Dis 1995; 14: 741-754.
3. Richter, S., Cormican, M.G., Pfaller, M.A. y cols. Fatal disseminated Trichoderma longibrachiatum infection in a adult bone marrow transplant patient: Species identification and review of literature. J Clin Microbiol 1999; 37: 1154-1160.
4. Verweij, P.E, Van de Bergh, M.F.Q., Rath, P.M., DePauw, B.E., Voss, A., Meis, J.F.G.M. Invasive aspergillosis caused by Aspergillus ustus: Case report and review. J Clin Microbiol 1999; 37: 1606-1609.
5. Gavin, P.J., Sutton, D.A., Katz, B.Z. Fatal endocarditis in a neonate caused by the dematiaceous fungus Phialemonium obovatum: Case report and review of the literature. J Clin Microbiol 2002; 40: 2207-2212.
6. Denning, D.W., Venkateswarlu, K., Oakley, L. y cols. Itraconazole resistance in Aspergillus fumigatus. Antimicrob. Agents Chemother 1997; 41: 1364-1368.
7. Iwen, P.C., Rupp, M.E., Langnas, L.N., Reed, E.C., Hinrichs, S.H. Invasive pulmonary aspergillosis due to Aspergillus terreus: 12-year experience and review of the literature. Clin Infect Dis 1998; 26: 1178-1184.
8. Fincher, R.M., Fisher, J.F., Lowell, R.D., Newman, C.L., Espinel-Ingroff, A., Shadomy, H.J. Infection due to the fungus Acremonium (Cephalosporium). Medicine (Balt.) 1991; 70: 398-409.
9. Guarro, J., Gams, W., Pujol, I. Gené, J.. Acremonium species: New emerging fungal opportunists in vitro antifungal susceptibilities and review. Clin Infect Dis 1997; 25: 1222-1229.
10. Schell, W.A., Perfect, J.R. Fatal disseminated Acremonium strictum infection in a neutropenic host. J Clin Microbiol 1996; 34: 1333-1336.
11. Roilides, E., Bibashi, E., Acritidou, E. y cols. Acremonium fungemia in two immunocompromised children. Pediatric Infect Dis J 1995; 14: 548-550.
12. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A. National Committee for Clinical Laboratory Standards, Wayne, Pa 2002.
13. Meletiadis, J., Mouton, J.W., Meis, J.F., Bouman, B.A., Verweij, P.E. Comparison of the E-test® and the Sensititre® colorimetric methods with the NCCLS proposed standard for antifungal susceptibility testing of Aspergillus species. J Clin Microbiol 2002; 40: 2876-2885.
14. Pfaller, M.A., Messer, S.A., Mills, K., Bolström, A. In vitro susceptibility testing of filamentous fungi: Comparison of E-test® and reference microdilution methods for determining itraconazole MIC. J Clin Microbiol 2000; 38: 3359-3361.
15. Pfaller, M.A., Messer, S.A., Karlsson, A., Bolström, A. Evaluation of the E-test® method for determining fluconazole susceptibilities of 402 clinical yeasts isolates by using three different agar media. J Clin Microbiol 1998; 36: 2586-2589.
16. Skezely, A., Johnson, E.M., Warnock, D.W. Comparison of E-test® and broth microdilution methods for antifungical drug susceptibility testing of molds. J Clin Microbiol 1999; 37: 1480-1483.
17. Espinel-Ingroff, A. Comparison of the E-test® with the NCCLS M38-P method for antifungal susceptebility testing of common and emerging pathogenic filamentous fungi. J Clin Microbiol 2001; 39: 1360-1367.
18. Linares, M.J., Muñoz, J. F., Solís, F., Rodríguez, F.C., Valero, A., Casal, M. Study of the susceptibilty of yeast isolates of clinical interests to five antifungal agents using the E-test®. Rev Esp Quimioterap 1998; 11: 64-69.
19. Carrillo-Muñoz, A.J., Quindós, G., Gasser, I. y cols. Determinación de la sensibilidad in vitro a los antifúngicos de levaduras de interés médico. Rev Esp Quimioter 1999; 12: 126-135.
20. Denning, D.W., Radford, S.A., Oakley, K.L., Hall, L., Johnson, E.M., Warnock, D.W. Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection. J Antimicrob Chemother 1997; 40: 401-414.
21. Espinel-Ingroff, A., Barlett, M., Chaturvedi, V. y cols. Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp: NCCLS collaborative evaluation. Antimicrob Agents Chemother 2001; 45: 1828-1835.
22. Odds, F.C., Van Gerven, F., Espinel-Ingroff, A. y cols. Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models. Antimicrob Agents Chemother 1998; 42: 282-288.
23. Wildfeuer, A., Seidl, H.P., Paule, I., Habereiter, A. In vitro evaluation of voriconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvin. Mycoses 1998; 41: 309-319.
24. Espinel-Ingroff, A. Clinical utility of in vitro antifungal susceptibility testing. Rev Esp Quimioterap 2000; 13: 161-166.